학술논문

Underutilization of pancreatic enzyme replacement therapy in pancreatic cancer and chronic pancreatitis.
Document Type
Article
Source
Journal of Internal Medicine. Nov2023, Vol. 294 Issue 5, p679-681. 3p.
Subject
*ENZYME replacement therapy
*PANCREATIC enzymes
*PANCREATIC cancer
*CHRONIC pancreatitis
*BONE fractures
*MEDICAL care
*CANCER treatment
Language
ISSN
0954-6820
Abstract
We retrospectively identified patients who were prescribed PERT for patients with an ICD10 diagnosis of CP or pancreatic cancer with a concomitant diagnosis of EPI. Dear Editor, Exocrine pancreatic insufficiency (EPI) is a major complication associated with several conditions, such as chronic pancreatitis (CP), pancreatic cancer, and cystic fibrosis [[1]]. Provider and patient education along with robust nutritional surveillance are crucial to mitigate underutilization of PERT among patients with EPI. [Extracted from the article]